Presentation is loading. Please wait.

Presentation is loading. Please wait.

Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,

Published byOtto Vítek Modified over 5 years ago

Similar presentations

Presentation on theme: "Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,"— Presentation transcript:

1 Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson, K. Eng, K.O. Odunsi, S. Shahabi  Gynecologic Oncology  Volume 141, (June 2016) DOI: /j.ygyno Copyright © Terms and Conditions

2 Fig. 1 Box Plot Data for CTCFAPα and CTCEpCAM Isolated from Blood of EOC Restricted Mean Survival as a Function of FZD3 Gene Expression. Gynecologic Oncology  , DOI: ( /j.ygyno ) Copyright © Terms and Conditions

Download ppt "Upregulated Wnt signaling is associated with increased survival of patients with high- grade serous ovarian cancer  M. Dandapani, B.L. Seagle, R. Samuelson,"

Similar presentations

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.

Design and Multiseries Validation of a Web-Based Gene Expression Assay for Predicting Breast Cancer Recurrence and Patient Survival Ryan K. Van Laar The.
Volume 144, Issue 1, Pages (January 2017)

Volume 144, Issue 1, Pages (January 2017)
Volume 145, Issue 1, Pages (April 2017)

Volume 145, Issue 1, Pages (April 2017)
Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.

Is vaccination with quadrivalent HPV vaccine after loop electrosurgical excision procedure effective in preventing recurrence in patients with high-grade.
Volume 150, Issue 1, Pages (July 2018)

Volume 150, Issue 1, Pages (July 2018)
Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)
Are patients willing to travel for better ovarian cancer care?

Are patients willing to travel for better ovarian cancer care?
Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)
L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L

L. C. Parsons, S. A. Sullivan, C. Garcia, T. Castellano, V. L
Volume 148, Issue 1, Pages (January 2018)

Volume 148, Issue 1, Pages (January 2018)
Volume 146, Issue 3, Pages (September 2017)

Volume 146, Issue 3, Pages (September 2017)
A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L

A. Melamed, E. J. Diver, A. A. Gockley, E. M. Hinchcliff, L
Pain in cancer survivors; filling in the gaps

Pain in cancer survivors; filling in the gaps
Volume 145, Issue 2, Pages (May 2017)

Volume 145, Issue 2, Pages (May 2017)
Vulvar intraepithelial neoplasia: Risk factors for recurrence

Vulvar intraepithelial neoplasia: Risk factors for recurrence
Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.

Corrigendum to “MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer” [Gynecologic Oncology 110: 13–21, 2008]  Douglas.
The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells

The efficacy of mTORC1/2 inhibition on ovarian cancer stem cells
Volume 141, Issue 2, Pages (May 2016)

Volume 141, Issue 2, Pages (May 2016)
M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns

M. Ulm, D. Lee, A.R. Mabe, M.P. Lowe, S. Kumar, T. Tillmanns
Volume 151, Issue 1, Pages (October 2018)

Volume 151, Issue 1, Pages (October 2018)

Similar presentations

Ads by Google